Most of what determines whether a protocol works is not the choice of molecule. It is the dose, the cadence, and the willingness of the provider to change both in response to what the body reports. Titration is the least glamorous part of a plan and, more often than not, the most decisive one.
This is a short behind-the-scenes look at how Aurevia providers approach dose refinement, and why the pace is intentionally patient.
Starting low is not caution — it is design
Beginning at a conservative dose is often described as caution. It is more accurately described as design. A gentle start lets the provider see how the individual physiology actually responds, minimizes side effects that can end a plan prematurely, and preserves optionality. Almost every good long-term outcome we see begins with a start that did not overreach.
The two questions that guide every adjustment
At each check-in, two questions are asked. First: is the plan producing the effect it was designed to produce, on the metrics that were agreed at the start? Second: is it doing so at an acceptable cost — side effects, labs, subjective experience? Every adjustment — up, down, or hold — is a considered answer to those two questions.
"The provider who is willing to hold or lower a dose is the provider most likely to raise it wisely when the moment comes."
What monitoring actually catches
On TRT, we watch total and free testosterone, estradiol, hematocrit and PSA on a defined cadence, and read them alongside sleep, mood and training response. On GLP-1 programs, we watch waist, lean-mass proxies, cardiometabolic labs, and adherence — not weekly weight in isolation. The point of monitoring is to catch the drift early enough that a small adjustment is sufficient.
- —A defined baseline and a defined re-check cadence.
- —Metrics that describe the outcome, not only the input.
- —Adjustments made by the provider, not by a template.
- —Explicit permission to hold, lower or de-escalate.
- —Secure messaging between visits, so change is not delayed.
De-escalation is a feature
The best protocols end on purpose. When a plan has done its work, or when a lower dose is now the right dose, we say so. That posture — that the plan is meant to change — is what keeps a long-term relationship honest.
Why cadence matters as much as dose
Weekly TRT dosing produces different peak-to-trough profiles than twice-weekly; the subjective experience often differs even at identical weekly totals. GLP-1 timing, injection site, and titration steps all shape tolerability. Cadence is part of the prescription, not an afterthought.
Read that way, titration is not a technical detail. It is the practice of medicine, quietly done.